BANK OF AMERICA CORP /DE/ - RUBIUS THERAPEUTICS INC ownership

RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 119 filers reported holding RUBIUS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of RUBIUS THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$3,375
+237.5%
19,286
+501.4%
0.00%
Q3 2022$1,000
-99.4%
3,207
-98.5%
0.00%
Q2 2022$180,000
-75.2%
211,551
+60.5%
0.00%
Q1 2022$726,000
+19.6%
131,797
+110.1%
0.00%
Q4 2021$607,000
-18.1%
62,724
+51.3%
0.00%
Q3 2021$741,000
+93.0%
41,456
+162.9%
0.00%
Q2 2021$384,000
-16.5%
15,771
-9.1%
0.00%
Q1 2021$460,000
+133.5%
17,358
-32.9%
0.00%
Q4 2020$197,000
+75.9%
25,871
+15.5%
0.00%
Q3 2020$112,000
+5.7%
22,403
+26.4%
0.00%
Q2 2020$106,000
+63.1%
17,725
+22.6%
0.00%
Q1 2020$65,000
-60.4%
14,453
-16.6%
0.00%
Q4 2019$164,000
-21.5%
17,324
-35.1%
0.00%
Q3 2019$209,000
-40.5%
26,676
+19.4%
0.00%
Q2 2019$351,000
+174.2%
22,343
+214.6%
0.00%
Q1 2019$128,000
-28.1%
7,103
-35.7%
0.00%
Q4 2018$178,000
+368.4%
11,048
+601.5%
0.00%
Q3 2018$38,0001,5750.00%
Other shareholders
RUBIUS THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 38,296,526$290,671,0005.29%
HARBOURVEST PARTNERS LLC 986,878$7,490,0002.93%
Abbot Financial Management, Inc. 537,000$4,076,0002.35%
Artal Group S.A. 3,778,913$28,682,0000.62%
HITE Hedge Asset Management LLC 88,740$674,0000.16%
Virtus ETF Advisers LLC 33,793$256,0000.11%
JACOBS LEVY EQUITY MANAGEMENT, INC 394,909$2,997,0000.03%
Baillie Gifford 4,710,061$35,749,0000.02%
Caption Management, LLC 86,000$652,0000.02%
Blueshift Asset Management, LLC 14,626$111,0000.01%
View complete list of RUBIUS THERAPEUTICS INC shareholders